awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55411384-041BC3AF-933A-4BD9-B2F8-01F81CBFFD19
Q55411384-041BC3AF-933A-4BD9-B2F8-01F81CBFFD19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55411384-041BC3AF-933A-4BD9-B2F8-01F81CBFFD19
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.
P2860
Q55411384-041BC3AF-933A-4BD9-B2F8-01F81CBFFD19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55411384-041BC3AF-933A-4BD9-B2F8-01F81CBFFD19
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f3b387e6757569e6b30452f01a42677f2e5e622
P2860
Effects of dapagliflozin on cardiovascular risk factors.